<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>BIOFINITY ‚Äî The Science of Immortality</title>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,300;0,400;0,600;1,300;1,400&family=Syne:wght@400;700;800&family=Space+Mono:ital@0;1&display=swap" rel="stylesheet">
<style>
  :root {
    --black: #030508;
    --deep: #060d1a;
    --navy: #0a1628;
    --blue: #0d2040;
    --accent: #00e5ff;
    --accent2: #7c3aed;
    --accent3: #10b981;
    --gold: #d4af37;
    --white: #f0f4ff;
    --muted: #8892a4;
    --text: #c8d4e8;
  }

  *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }

  html { scroll-behavior: smooth; }

  body {
    background: var(--black);
    color: var(--text);
    font-family: 'Cormorant Garamond', serif;
    font-size: 18px;
    overflow-x: hidden;
    cursor: none;
  }

  /* Custom cursor */
  .cursor {
    width: 8px; height: 8px;
    background: var(--accent);
    border-radius: 50%;
    position: fixed;
    pointer-events: none;
    z-index: 9999;
    transition: transform 0.1s;
    mix-blend-mode: screen;
  }
  .cursor-ring {
    width: 40px; height: 40px;
    border: 1px solid rgba(0, 229, 255, 0.4);
    border-radius: 50%;
    position: fixed;
    pointer-events: none;
    z-index: 9998;
    transition: all 0.15s ease;
    transform: translate(-50%, -50%);
  }

  /* Noise overlay */
  body::before {
    content: '';
    position: fixed;
    inset: 0;
    background-image: url("data:image/svg+xml,%3Csvg viewBox='0 0 256 256' xmlns='http://www.w3.org/2000/svg'%3E%3Cfilter id='noise'%3E%3CfeTurbulence type='fractalNoise' baseFrequency='0.9' numOctaves='4' stitchTiles='stitch'/%3E%3C/filter%3E%3Crect width='100%25' height='100%25' filter='url(%23noise)' opacity='0.04'/%3E%3C/svg%3E");
    opacity: 0.4;
    pointer-events: none;
    z-index: 1;
  }

  /* ====== NAVIGATION ====== */
  nav {
    position: fixed;
    top: 0; left: 0; right: 0;
    z-index: 100;
    padding: 24px 60px;
    display: flex;
    justify-content: space-between;
    align-items: center;
    background: linear-gradient(to bottom, rgba(3,5,8,0.95), transparent);
    backdrop-filter: blur(2px);
  }

  .logo {
    font-family: 'Syne', sans-serif;
    font-weight: 800;
    font-size: 22px;
    letter-spacing: 0.3em;
    color: var(--white);
    text-decoration: none;
  }
  .logo span { color: var(--accent); }

  .nav-links {
    display: flex;
    gap: 40px;
    list-style: none;
  }
  .nav-links a {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.15em;
    color: var(--muted);
    text-decoration: none;
    text-transform: uppercase;
    transition: color 0.3s;
  }
  .nav-links a:hover { color: var(--accent); }

  /* ====== HERO ====== */
  .hero {
    min-height: 100vh;
    display: flex;
    flex-direction: column;
    justify-content: center;
    align-items: center;
    text-align: center;
    position: relative;
    overflow: hidden;
    padding: 120px 40px 80px;
  }

  .hero-bg {
    position: absolute;
    inset: 0;
    background:
      radial-gradient(ellipse 80% 60% at 50% 100%, rgba(13,32,64,0.8) 0%, transparent 70%),
      radial-gradient(ellipse 60% 40% at 20% 20%, rgba(124,58,237,0.15) 0%, transparent 60%),
      radial-gradient(ellipse 40% 30% at 80% 30%, rgba(0,229,255,0.08) 0%, transparent 50%),
      var(--black);
  }

  /* Animated grid */
  .grid-lines {
    position: absolute;
    inset: 0;
    background-image:
      linear-gradient(rgba(0,229,255,0.03) 1px, transparent 1px),
      linear-gradient(90deg, rgba(0,229,255,0.03) 1px, transparent 1px);
    background-size: 80px 80px;
    animation: gridMove 20s linear infinite;
  }
  @keyframes gridMove {
    0% { transform: translateY(0); }
    100% { transform: translateY(80px); }
  }

  /* DNA helix animation */
  .dna-container {
    position: absolute;
    right: -80px;
    top: 50%;
    transform: translateY(-50%);
    width: 300px;
    height: 600px;
    opacity: 0.15;
  }

  .hero-eyebrow {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.4em;
    color: var(--accent);
    text-transform: uppercase;
    margin-bottom: 32px;
    position: relative;
    z-index: 2;
    animation: fadeInUp 1s 0.2s both;
  }
  .hero-eyebrow::before, .hero-eyebrow::after {
    content: '‚Äî';
    margin: 0 16px;
    color: rgba(0,229,255,0.4);
  }

  h1 {
    font-family: 'Cormorant Garamond', serif;
    font-size: clamp(64px, 10vw, 140px);
    font-weight: 300;
    line-height: 0.9;
    color: var(--white);
    position: relative;
    z-index: 2;
    animation: fadeInUp 1s 0.4s both;
    letter-spacing: -0.02em;
  }
  h1 em {
    font-style: italic;
    color: var(--accent);
    display: block;
  }

  .hero-sub {
    max-width: 600px;
    margin: 40px auto 0;
    font-size: 20px;
    font-weight: 300;
    color: var(--muted);
    line-height: 1.8;
    position: relative;
    z-index: 2;
    animation: fadeInUp 1s 0.6s both;
  }

  .hero-cta {
    display: flex;
    gap: 20px;
    margin-top: 60px;
    position: relative;
    z-index: 2;
    animation: fadeInUp 1s 0.8s both;
  }

  .btn-primary {
    font-family: 'Space Mono', monospace;
    font-size: 12px;
    letter-spacing: 0.2em;
    text-transform: uppercase;
    padding: 16px 40px;
    background: var(--accent);
    color: var(--black);
    border: none;
    text-decoration: none;
    font-weight: 700;
    transition: all 0.3s;
    position: relative;
    overflow: hidden;
  }
  .btn-primary::before {
    content: '';
    position: absolute;
    inset: 0;
    background: var(--white);
    transform: translateX(-100%);
    transition: transform 0.3s;
  }
  .btn-primary:hover::before { transform: translateX(0); }
  .btn-primary span { position: relative; z-index: 1; }

  .btn-secondary {
    font-family: 'Space Mono', monospace;
    font-size: 12px;
    letter-spacing: 0.2em;
    text-transform: uppercase;
    padding: 16px 40px;
    background: transparent;
    color: var(--white);
    border: 1px solid rgba(255,255,255,0.2);
    text-decoration: none;
    transition: all 0.3s;
  }
  .btn-secondary:hover { border-color: var(--accent); color: var(--accent); }

  .scroll-indicator {
    position: absolute;
    bottom: 40px;
    left: 50%;
    transform: translateX(-50%);
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 8px;
    z-index: 2;
    animation: fadeInUp 1s 1s both;
  }
  .scroll-line {
    width: 1px;
    height: 60px;
    background: linear-gradient(to bottom, var(--accent), transparent);
    animation: scrollPulse 2s ease-in-out infinite;
  }
  @keyframes scrollPulse {
    0%, 100% { opacity: 0.3; transform: scaleY(1); }
    50% { opacity: 1; transform: scaleY(1.2); }
  }
  .scroll-text {
    font-family: 'Space Mono', monospace;
    font-size: 9px;
    letter-spacing: 0.3em;
    color: var(--muted);
    text-transform: uppercase;
    writing-mode: vertical-rl;
  }

  /* ====== STATS BAR ====== */
  .stats-bar {
    background: var(--deep);
    border-top: 1px solid rgba(0,229,255,0.1);
    border-bottom: 1px solid rgba(0,229,255,0.1);
    padding: 40px 60px;
    display: grid;
    grid-template-columns: repeat(4, 1fr);
    gap: 40px;
  }
  .stat-item {
    text-align: center;
    position: relative;
  }
  .stat-item + .stat-item::before {
    content: '';
    position: absolute;
    left: 0;
    top: 10%;
    height: 80%;
    width: 1px;
    background: rgba(255,255,255,0.06);
  }
  .stat-num {
    font-family: 'Syne', sans-serif;
    font-size: 48px;
    font-weight: 800;
    color: var(--accent);
    display: block;
    line-height: 1;
  }
  .stat-label {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.2em;
    color: var(--muted);
    text-transform: uppercase;
    margin-top: 8px;
  }

  /* ====== SECTION COMMON ====== */
  section {
    padding: 120px 60px;
    position: relative;
  }

  .section-label {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.4em;
    color: var(--accent);
    text-transform: uppercase;
    margin-bottom: 20px;
    display: flex;
    align-items: center;
    gap: 16px;
  }
  .section-label::after {
    content: '';
    flex: 1;
    max-width: 60px;
    height: 1px;
    background: var(--accent);
    opacity: 0.4;
  }

  h2 {
    font-family: 'Cormorant Garamond', serif;
    font-size: clamp(40px, 5vw, 72px);
    font-weight: 300;
    line-height: 1.1;
    color: var(--white);
    letter-spacing: -0.02em;
    margin-bottom: 24px;
  }
  h2 em { font-style: italic; color: var(--accent); }

  h3 {
    font-family: 'Syne', sans-serif;
    font-size: 18px;
    font-weight: 700;
    color: var(--white);
    letter-spacing: 0.05em;
    margin-bottom: 16px;
  }

  p {
    line-height: 1.9;
    color: var(--text);
    font-weight: 300;
  }

  /* ====== AGING SECTION ====== */
  .aging-intro {
    background: var(--deep);
  }

  .aging-grid {
    display: grid;
    grid-template-columns: 1fr 1fr;
    gap: 80px;
    align-items: center;
    max-width: 1200px;
    margin: 0 auto;
  }

  .hallmarks-title {
    font-family: 'Cormorant Garamond', serif;
    font-size: 28px;
    font-weight: 300;
    color: var(--white);
    margin: 60px 0 32px;
  }

  .hallmarks-grid {
    display: grid;
    grid-template-columns: repeat(3, 1fr);
    gap: 16px;
    max-width: 1200px;
    margin: 0 auto;
  }

  .hallmark-card {
    background: rgba(13,32,64,0.4);
    border: 1px solid rgba(0,229,255,0.1);
    padding: 28px 24px;
    position: relative;
    overflow: hidden;
    transition: all 0.4s;
  }
  .hallmark-card::before {
    content: '';
    position: absolute;
    top: 0; left: 0;
    width: 3px;
    height: 100%;
    background: var(--accent);
    transform: scaleY(0);
    transform-origin: bottom;
    transition: transform 0.4s;
  }
  .hallmark-card:hover { border-color: rgba(0,229,255,0.3); transform: translateY(-4px); }
  .hallmark-card:hover::before { transform: scaleY(1); }

  .hallmark-num {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    color: var(--accent);
    opacity: 0.5;
    letter-spacing: 0.2em;
    margin-bottom: 12px;
  }
  .hallmark-card h4 {
    font-family: 'Syne', sans-serif;
    font-size: 14px;
    font-weight: 700;
    color: var(--white);
    letter-spacing: 0.05em;
    margin-bottom: 10px;
    text-transform: uppercase;
  }
  .hallmark-card p {
    font-size: 14px;
    line-height: 1.7;
    color: var(--muted);
  }

  /* ====== THEORIES SECTION ====== */
  .theories-section {
    background: var(--black);
  }

  .theory-row {
    display: grid;
    grid-template-columns: 1fr 2fr;
    gap: 60px;
    max-width: 1200px;
    margin: 60px auto 0;
    padding: 48px 0;
    border-bottom: 1px solid rgba(255,255,255,0.05);
    transition: all 0.4s;
    align-items: start;
  }
  .theory-row:hover { border-bottom-color: rgba(0,229,255,0.2); }
  .theory-row:last-child { border-bottom: none; }

  .theory-number {
    font-family: 'Syne', sans-serif;
    font-size: 80px;
    font-weight: 800;
    color: rgba(0,229,255,0.06);
    line-height: 1;
    transition: color 0.4s;
  }
  .theory-row:hover .theory-number { color: rgba(0,229,255,0.12); }

  .theory-tag {
    display: inline-block;
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.2em;
    color: var(--accent3);
    border: 1px solid rgba(16,185,129,0.3);
    padding: 4px 12px;
    margin-bottom: 16px;
    text-transform: uppercase;
  }

  /* ====== INTERVENTIONS ====== */
  .interventions-section {
    background: var(--deep);
  }

  .interventions-tabs {
    display: flex;
    gap: 0;
    border-bottom: 1px solid rgba(255,255,255,0.08);
    margin-bottom: 60px;
    max-width: 1200px;
    margin-left: auto;
    margin-right: auto;
    overflow-x: auto;
  }

  .tab-btn {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.15em;
    text-transform: uppercase;
    color: var(--muted);
    background: none;
    border: none;
    border-bottom: 2px solid transparent;
    padding: 16px 28px;
    cursor: none;
    transition: all 0.3s;
    white-space: nowrap;
  }
  .tab-btn.active, .tab-btn:hover { color: var(--white); border-bottom-color: var(--accent); }

  .tab-content { display: none; max-width: 1200px; margin: 0 auto; }
  .tab-content.active { display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px; }

  .intervention-card {
    background: rgba(3,5,8,0.6);
    border: 1px solid rgba(255,255,255,0.06);
    padding: 36px 28px;
    position: relative;
    overflow: hidden;
    transition: all 0.4s;
  }
  .intervention-card::after {
    content: '';
    position: absolute;
    bottom: 0; left: 0; right: 0;
    height: 2px;
    background: linear-gradient(90deg, var(--accent), var(--accent2));
    transform: scaleX(0);
    transition: transform 0.4s;
  }
  .intervention-card:hover { transform: translateY(-6px); border-color: rgba(0,229,255,0.15); }
  .intervention-card:hover::after { transform: scaleX(1); }

  .card-icon {
    font-size: 32px;
    margin-bottom: 20px;
    display: block;
  }
  .card-status {
    font-family: 'Space Mono', monospace;
    font-size: 9px;
    letter-spacing: 0.2em;
    text-transform: uppercase;
    padding: 4px 10px;
    display: inline-block;
    margin-bottom: 16px;
  }
  .status-clinical { color: var(--accent3); background: rgba(16,185,129,0.1); border: 1px solid rgba(16,185,129,0.2); }
  .status-research { color: var(--accent); background: rgba(0,229,255,0.1); border: 1px solid rgba(0,229,255,0.2); }
  .status-theoretical { color: var(--gold); background: rgba(212,175,55,0.1); border: 1px solid rgba(212,175,55,0.2); }
  .status-emerging { color: var(--accent2); background: rgba(124,58,237,0.1); border: 1px solid rgba(124,58,237,0.2); }

  .intervention-card h4 {
    font-family: 'Syne', sans-serif;
    font-size: 16px;
    font-weight: 700;
    color: var(--white);
    margin-bottom: 12px;
    letter-spacing: 0.03em;
  }
  .intervention-card p {
    font-size: 15px;
    color: var(--muted);
    line-height: 1.75;
  }

  /* ====== ROADMAP ====== */
  .roadmap-section {
    background: var(--black);
    overflow: hidden;
  }

  .timeline {
    max-width: 900px;
    margin: 80px auto 0;
    position: relative;
  }
  .timeline::before {
    content: '';
    position: absolute;
    left: 50%;
    top: 0; bottom: 0;
    width: 1px;
    background: linear-gradient(to bottom, transparent, rgba(0,229,255,0.3), transparent);
    transform: translateX(-50%);
  }

  .timeline-item {
    display: grid;
    grid-template-columns: 1fr 60px 1fr;
    gap: 0;
    margin-bottom: 60px;
    align-items: start;
  }
  .timeline-item.right .timeline-content { grid-column: 3; text-align: left; }
  .timeline-item.right .timeline-content-empty { grid-column: 1; }
  .timeline-item.left .timeline-content { grid-column: 1; text-align: right; }
  .timeline-item.left .timeline-content-empty { grid-column: 3; }

  .timeline-dot {
    grid-column: 2;
    display: flex;
    justify-content: center;
    align-items: center;
    padding-top: 8px;
  }
  .dot {
    width: 12px; height: 12px;
    background: var(--accent);
    border-radius: 50%;
    box-shadow: 0 0 20px var(--accent);
    position: relative;
  }
  .dot::before {
    content: '';
    position: absolute;
    inset: -6px;
    border: 1px solid rgba(0,229,255,0.3);
    border-radius: 50%;
  }

  .timeline-content {
    padding: 0 32px;
  }
  .timeline-year {
    font-family: 'Syne', sans-serif;
    font-size: 28px;
    font-weight: 800;
    color: var(--accent);
    line-height: 1;
    margin-bottom: 8px;
  }
  .timeline-content h4 {
    font-family: 'Syne', sans-serif;
    font-size: 15px;
    font-weight: 700;
    color: var(--white);
    margin-bottom: 10px;
    letter-spacing: 0.03em;
  }
  .timeline-content p {
    font-size: 14px;
    color: var(--muted);
    line-height: 1.7;
  }

  /* ====== HYPOTHESES ====== */
  .hypotheses-section {
    background: var(--deep);
  }

  .hypothesis-accordion {
    max-width: 900px;
    margin: 60px auto 0;
  }

  .accordion-item {
    border-bottom: 1px solid rgba(255,255,255,0.06);
    overflow: hidden;
  }

  .accordion-header {
    display: flex;
    justify-content: space-between;
    align-items: center;
    padding: 28px 0;
    cursor: none;
    transition: all 0.3s;
  }
  .accordion-header:hover h4 { color: var(--accent); }

  .accordion-header h4 {
    font-family: 'Syne', sans-serif;
    font-size: 18px;
    font-weight: 700;
    color: var(--white);
    transition: color 0.3s;
  }
  .accordion-icon {
    width: 32px; height: 32px;
    border: 1px solid rgba(0,229,255,0.3);
    display: flex;
    align-items: center;
    justify-content: center;
    color: var(--accent);
    font-size: 20px;
    transition: all 0.3s;
    flex-shrink: 0;
  }
  .accordion-item.open .accordion-icon { transform: rotate(45deg); background: rgba(0,229,255,0.1); }

  .accordion-body {
    max-height: 0;
    overflow: hidden;
    transition: max-height 0.5s ease;
  }
  .accordion-item.open .accordion-body { max-height: 400px; }

  .accordion-body-inner {
    padding: 0 0 28px;
    color: var(--muted);
    font-size: 16px;
    line-height: 1.85;
  }

  /* ====== COMPANIES ====== */
  .companies-section {
    background: var(--black);
    text-align: center;
  }

  .companies-grid {
    display: grid;
    grid-template-columns: repeat(4, 1fr);
    gap: 2px;
    max-width: 1200px;
    margin: 60px auto 0;
    background: rgba(255,255,255,0.04);
  }

  .company-cell {
    background: var(--black);
    padding: 40px 24px;
    transition: all 0.4s;
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 12px;
  }
  .company-cell:hover {
    background: rgba(0,229,255,0.05);
  }
  .company-name {
    font-family: 'Syne', sans-serif;
    font-size: 16px;
    font-weight: 800;
    color: var(--white);
    letter-spacing: 0.05em;
  }
  .company-desc {
    font-size: 13px;
    color: var(--muted);
    text-align: center;
    line-height: 1.6;
  }
  .company-focus {
    font-family: 'Space Mono', monospace;
    font-size: 9px;
    letter-spacing: 0.2em;
    color: var(--accent);
    text-transform: uppercase;
  }

  /* ====== MANIFESTO ====== */
  .manifesto {
    min-height: 80vh;
    display: flex;
    align-items: center;
    justify-content: center;
    text-align: center;
    background: var(--deep);
    position: relative;
    overflow: hidden;
  }
  .manifesto::before {
    content: '';
    position: absolute;
    inset: 0;
    background: radial-gradient(ellipse 80% 60% at 50% 50%, rgba(0,229,255,0.05) 0%, transparent 70%);
  }

  .manifesto-inner {
    max-width: 800px;
    padding: 40px;
    position: relative;
    z-index: 2;
  }

  .manifesto-quote {
    font-size: clamp(28px, 4vw, 52px);
    font-weight: 300;
    line-height: 1.3;
    color: var(--white);
    margin-bottom: 40px;
  }
  .manifesto-quote em { font-style: italic; color: var(--accent); }

  /* ====== FOOTER ====== */
  footer {
    background: var(--black);
    border-top: 1px solid rgba(255,255,255,0.05);
    padding: 60px;
    display: flex;
    justify-content: space-between;
    align-items: center;
  }

  .footer-logo {
    font-family: 'Syne', sans-serif;
    font-weight: 800;
    font-size: 20px;
    letter-spacing: 0.3em;
    color: var(--white);
  }
  .footer-logo span { color: var(--accent); }

  .footer-text {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.15em;
    color: var(--muted);
    text-transform: uppercase;
    text-align: center;
  }

  .footer-links {
    display: flex;
    gap: 32px;
  }
  .footer-links a {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.15em;
    color: var(--muted);
    text-decoration: none;
    text-transform: uppercase;
    transition: color 0.3s;
  }
  .footer-links a:hover { color: var(--accent); }

  /* ====== ANIMATIONS ====== */
  @keyframes fadeInUp {
    from { opacity: 0; transform: translateY(30px); }
    to { opacity: 1; transform: translateY(0); }
  }

  .fade-in {
    opacity: 0;
    transform: translateY(40px);
    transition: opacity 0.8s ease, transform 0.8s ease;
  }
  .fade-in.visible {
    opacity: 1;
    transform: translateY(0);
  }

  /* SVG DNA */
  .dna-svg { width: 100%; height: 100%; }

  /* Glowing orb */
  .orb {
    position: absolute;
    border-radius: 50%;
    filter: blur(80px);
    pointer-events: none;
  }

  @media (max-width: 900px) {
    nav { padding: 20px 24px; }
    .nav-links { display: none; }
    section { padding: 80px 24px; }
    .stats-bar { grid-template-columns: repeat(2, 1fr); padding: 40px 24px; }
    .aging-grid { grid-template-columns: 1fr; gap: 40px; }
    .hallmarks-grid { grid-template-columns: repeat(2, 1fr); }
    .tab-content.active { grid-template-columns: 1fr; }
    .companies-grid { grid-template-columns: repeat(2, 1fr); }
    .timeline::before { left: 20px; }
    .timeline-item { grid-template-columns: 1fr; padding-left: 52px; }
    .timeline-dot { display: none; }
    footer { flex-direction: column; gap: 24px; text-align: center; }
    .footer-links { flex-wrap: wrap; justify-content: center; }
  }
</style>
</head>
<body>

<!-- Cursor -->
<div class="cursor" id="cursor"></div>
<div class="cursor-ring" id="cursorRing"></div>

<!-- Navigation -->
<nav>
  <a href="#" class="logo">BIO<span>FIN</span>ITY</a>
  <ul class="nav-links">
    <li><a href="#aging">Biology of Aging</a></li>
    <li><a href="#theories">Theories</a></li>
    <li><a href="#interventions">Interventions</a></li>
    <li><a href="#roadmap">Roadmap</a></li>
    <li><a href="#hypotheses">Hypotheses</a></li>
  </ul>
</nav>

<!-- Hero -->
<section class="hero">
  <div class="hero-bg"></div>
  <div class="grid-lines"></div>

  <!-- Animated orbs -->
  <div class="orb" style="width:500px;height:500px;background:rgba(0,229,255,0.04);top:-100px;left:-100px;"></div>
  <div class="orb" style="width:400px;height:400px;background:rgba(124,58,237,0.06);bottom:-50px;right:-50px;animation:orbFloat 8s ease-in-out infinite;"></div>

  <div class="hero-eyebrow">Aging Biology & Longevity Science</div>

  <h1>
    Defeat<br>
    <em>Aging.</em>
    Live Forever.
  </h1>

  <p class="hero-sub">
    A comprehensive exploration of the biology of aging ‚Äî the mechanisms, the hypotheses, the emerging technologies, and the scientific pathways toward radical life extension and human immortality.
  </p>

  <div class="hero-cta">
    <a href="#aging" class="btn-primary"><span>Explore the Science</span></a>
    <a href="#roadmap" class="btn-secondary">View Roadmap</a>
  </div>

  <div class="scroll-indicator">
    <div class="scroll-line"></div>
    <span class="scroll-text">Scroll</span>
  </div>
</section>

<!-- Stats Bar -->
<div class="stats-bar">
  <div class="stat-item fade-in">
    <span class="stat-num">150T</span>
    <span class="stat-label">Cells in the human body</span>
  </div>
  <div class="stat-item fade-in">
    <span class="stat-num">12</span>
    <span class="stat-label">Hallmarks of aging</span>
  </div>
  <div class="stat-item fade-in">
    <span class="stat-num">$5B+</span>
    <span class="stat-label">Annual longevity investment</span>
  </div>
  <div class="stat-item fade-in">
    <span class="stat-num">2050</span>
    <span class="stat-label">Projected escape velocity</span>
  </div>
</div>

<!-- Aging Biology -->
<section class="aging-intro" id="aging">
  <div class="aging-grid">
    <div class="fade-in">
      <div class="section-label">01 ‚Äî The Problem</div>
      <h2>What is <em>Aging?</em></h2>
      <p style="margin-bottom:20px;">Aging is the progressive, time-dependent deterioration of biological function ‚Äî a cascade of molecular damage, cellular dysfunction, and systemic decline that ultimately leads to disease and death. It is not inevitable in principle; it is a biological process governed by genes, proteins, and metabolic pathways that can be targeted.</p>
      <p>Modern biology has identified aging not as a random decay but as a defined set of molecular hallmarks ‚Äî interconnected processes that drive organismal deterioration. Understanding these mechanisms is the first step toward defeating them.</p>
    </div>
    <div class="fade-in">
      <div style="background: rgba(0,229,255,0.03); border: 1px solid rgba(0,229,255,0.1); padding: 40px; position: relative; overflow: hidden;">
        <div style="position:absolute;top:-20px;right:-20px;width:150px;height:150px;background:radial-gradient(circle,rgba(0,229,255,0.08),transparent 70%);border-radius:50%;"></div>
        <div class="section-label" style="margin-bottom:24px;">Key Insight</div>
        <p style="font-size:22px;font-weight:300;color:var(--white);line-height:1.6;font-style:italic;">"Aging is not a program ‚Äî it is the accumulation of molecular damage over time. And damage can be repaired."</p>
        <p style="margin-top:24px;font-family:'Space Mono',monospace;font-size:11px;color:var(--muted);">‚Äî Aubrey de Grey, SENS Research Foundation</p>
      </div>
    </div>
  </div>

  <div style="max-width:1200px;margin:0 auto;">
    <h3 class="hallmarks-title fade-in">The 12 Hallmarks of Aging</h3>
    <div class="hallmarks-grid">
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">01 / 12</div>
        <h4>Genomic Instability</h4>
        <p>DNA damage accumulates throughout life from radiation, metabolic byproducts, and replication errors, impairing cellular function and driving cancer.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">02 / 12</div>
        <h4>Telomere Attrition</h4>
        <p>Protective chromosomal caps shorten with each cell division, eventually triggering senescence or apoptosis and limiting cellular lifespan.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">03 / 12</div>
        <h4>Epigenetic Alterations</h4>
        <p>Chemical modifications to DNA and histones change gene expression patterns, disrupting cellular identity and function over time.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">04 / 12</div>
        <h4>Loss of Proteostasis</h4>
        <p>The protein quality control system degrades, allowing misfolded proteins to accumulate ‚Äî the hallmark of Alzheimer's, Parkinson's, and other age-related diseases.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">05 / 12</div>
        <h4>Disabled Macroautophagy</h4>
        <p>The cellular recycling system that clears damaged components becomes impaired, allowing cellular debris to build up and impair function.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">06 / 12</div>
        <h4>Deregulated Nutrient Sensing</h4>
        <p>mTOR, IGF-1, AMPK, and sirtuins pathways become dysregulated, impairing metabolic homeostasis and accelerating cellular aging.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">07 / 12</div>
        <h4>Mitochondrial Dysfunction</h4>
        <p>The cellular powerhouses accumulate mutations and become less efficient, increasing oxidative stress and reducing energy production capacity.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">08 / 12</div>
        <h4>Cellular Senescence</h4>
        <p>Damaged cells stop dividing but resist apoptosis, secreting inflammatory molecules (SASP) that damage surrounding tissue and promote systemic aging.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">09 / 12</div>
        <h4>Stem Cell Exhaustion</h4>
        <p>The regenerative capacity of tissues declines as stem cell pools deplete, reducing the body's ability to repair and maintain organs.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">10 / 12</div>
        <h4>Altered Intercellular Communication</h4>
        <p>Chronic inflammation, changes in hormonal signaling, and disrupted cell-to-cell communication contribute to systemic aging.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">11 / 12</div>
        <h4>Chronic Inflammation</h4>
        <p>"Inflammaging" ‚Äî the persistent low-grade inflammatory state that develops with age ‚Äî drives neurodegeneration, cardiovascular disease, and metabolic disorders.</p>
      </div>
      <div class="hallmark-card fade-in">
        <div class="hallmark-num">12 / 12</div>
        <h4>Dysbiosis</h4>
        <p>Changes in the gut microbiome composition affect immunity, metabolism, and brain health, contributing to systemic age-related decline.</p>
      </div>
    </div>
  </div>
</section>

<!-- Theories of Aging -->
<section class="theories-section" id="theories">
  <div class="section-label fade-in">02 ‚Äî Why We Age</div>
  <h2 class="fade-in">Major <em>Theories</em><br>of Aging</h2>
  <p class="fade-in" style="max-width:600px;">Science has proposed dozens of mechanisms to explain aging. These are not mutually exclusive ‚Äî they likely all contribute, creating a complex web of interconnected processes.</p>

  <div style="max-width:1200px;margin:0 auto;">
    <div class="theory-row fade-in">
      <div class="theory-number">01</div>
      <div>
        <span class="theory-tag">Molecular</span>
        <h3>The Free Radical Theory</h3>
        <p>Proposed by Denham Harman in 1956, this theory holds that reactive oxygen species (ROS) produced during cellular metabolism cause cumulative damage to DNA, proteins, and lipids. While antioxidant therapies alone have failed as anti-aging treatments, mitochondrial-targeted antioxidants remain promising. Modern refinements focus on mitochondrial ROS as the primary aging driver.</p>
      </div>
    </div>

    <div class="theory-row fade-in">
      <div class="theory-number">02</div>
      <div>
        <span class="theory-tag">Genetic</span>
        <h3>The Telomere Theory</h3>
        <p>Every time a cell divides, telomeres ‚Äî repetitive DNA sequences capping chromosomes ‚Äî shorten. When they become critically short, cells enter replicative senescence or die. Telomerase, the enzyme that rebuilds telomeres, is suppressed in most adult cells. Activating telomerase could potentially reset cellular age, though cancer risk is a key concern requiring careful management.</p>
      </div>
    </div>

    <div class="theory-row fade-in">
      <div class="theory-number">03</div>
      <div>
        <span class="theory-tag">Epigenetic</span>
        <h3>The Epigenetic Clock Theory</h3>
        <p>Steve Horvath's discovery that DNA methylation patterns correlate precisely with biological age (the "epigenetic clock") revolutionized aging research. This suggests aging is partly programmed through epigenetic changes. Crucially, these changes can potentially be reversed ‚Äî partial reprogramming using Yamanaka factors has reset epigenetic age in multiple organisms without inducing cancer.</p>
      </div>
    </div>

    <div class="theory-row fade-in">
      <div class="theory-number">04</div>
      <div>
        <span class="theory-tag">Systems</span>
        <h3>The Disposable Soma Theory</h3>
        <p>Proposed by Tom Kirkwood, this evolutionary theory argues that organisms invest limited resources in reproduction versus somatic maintenance. Aging results from insufficient investment in self-repair. This explains why caloric restriction extends lifespan ‚Äî reduced reproduction diverts resources to maintenance. It predicts that enhancing repair mechanisms could directly extend healthy lifespan.</p>
      </div>
    </div>

    <div class="theory-row fade-in">
      <div class="theory-number">05</div>
      <div>
        <span class="theory-tag">Information</span>
        <h3>The Information Theory of Aging</h3>
        <p>David Sinclair's recent framework proposes that aging is a loss of epigenetic information ‚Äî the cellular "software" becomes corrupted over time, not the DNA "hardware." Cells lose the ability to read their own genome correctly. Restoring this information through epigenetic reprogramming could potentially reverse aging at the cellular level, treating age itself as a disease to be cured.</p>
      </div>
    </div>

    <div class="theory-row fade-in">
      <div class="theory-number">06</div>
      <div>
        <span class="theory-tag">Proteome</span>
        <h3>The Proteostasis Theory</h3>
        <p>The protein homeostasis network ‚Äî chaperones, the ubiquitin-proteasome system, and autophagy ‚Äî maintains the proteome's integrity. With age, this network declines, allowing toxic protein aggregates to accumulate. Boosting proteostasis through targeted interventions may clear the molecular debris that drives neurodegeneration and other age-related diseases.</p>
      </div>
    </div>
  </div>
</section>

<!-- Interventions -->
<section class="interventions-section" id="interventions">
  <div class="section-label fade-in">03 ‚Äî How to Fight Aging</div>
  <h2 class="fade-in">Interventions &<br><em>Therapies</em></h2>
  <p class="fade-in" style="max-width:600px;margin-bottom:60px;">From proven lifestyle interventions to cutting-edge gene therapies, here are all current and proposed methods to slow, stop, or reverse aging.</p>

  <div class="interventions-tabs" id="tabsContainer">
    <button class="tab-btn active" onclick="switchTab('lifestyle')">Lifestyle</button>
    <button class="tab-btn" onclick="switchTab('pharmacological')">Pharmacological</button>
    <button class="tab-btn" onclick="switchTab('genetic')">Genetic & Cellular</button>
    <button class="tab-btn" onclick="switchTab('emerging')">Emerging Tech</button>
    <button class="tab-btn" onclick="switchTab('radical')">Radical Approaches</button>
  </div>

  <!-- Lifestyle -->
  <div class="tab-content active" id="tab-lifestyle">
    <div class="intervention-card fade-in">
      <span class="card-icon">üçΩÔ∏è</span>
      <span class="card-status status-clinical">Clinically proven</span>
      <h4>Caloric Restriction</h4>
      <p>Reducing calorie intake by 20-40% without malnutrition activates longevity pathways (AMPK, sirtuins) and extends lifespan in every organism tested, from yeast to primates. The CALERIE trial confirmed benefits in humans.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">‚è∞</span>
      <span class="card-status status-clinical">Clinically proven</span>
      <h4>Time-Restricted Eating</h4>
      <p>Confining eating to 6-10 hours activates autophagy (cellular recycling), improves metabolic markers, reduces inflammation, and mimics caloric restriction benefits without reducing total calories.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üèÉ</span>
      <span class="card-status status-clinical">Clinically proven</span>
      <h4>Exercise</h4>
      <p>The most potent single intervention: aerobic exercise lengthens telomeres, reduces senescent cell burden, stimulates neurogenesis, improves mitochondrial function, and reduces all-cause mortality by 30-40%.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üò¥</span>
      <span class="card-status status-clinical">Clinically proven</span>
      <h4>Sleep Optimization</h4>
      <p>Deep sleep activates the glymphatic system to clear brain waste including amyloid-beta. Chronic sleep deprivation accelerates epigenetic aging by 1-2 years per decade. 7-9 hours nightly is optimal.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üßä</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Cold Exposure</h4>
      <p>Cold exposure activates brown adipose tissue, increases norepinephrine, reduces inflammation, and activates cold-shock proteins that improve proteostasis and may have longevity benefits.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üßò</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Stress Reduction</h4>
      <p>Chronic stress accelerates telomere shortening and epigenetic aging via cortisol and inflammatory pathways. Meditation has shown measurable epigenetic age reversal in clinical studies.</p>
    </div>
  </div>

  <!-- Pharmacological -->
  <div class="tab-content" id="tab-pharmacological">
    <div class="intervention-card fade-in">
      <span class="card-icon">üíä</span>
      <span class="card-status status-clinical">Clinically available</span>
      <h4>Metformin</h4>
      <p>The world's most prescribed diabetes drug activates AMPK and inhibits mTOR, mimicking caloric restriction. The TAME trial is testing it as the first FDA-approved anti-aging drug. Epidemiological data shows diabetics on metformin outlive non-diabetics not on it.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üî¨</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Rapamycin</h4>
      <p>mTOR inhibitor that extended lifespan in mice by up to 60% even when started in old age. The most reproducible life extension result in mammals. Clinical trials are underway. Weekly dosing minimizes immunosuppressive side effects.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">‚ö°</span>
      <span class="card-status status-research">Active Research</span>
      <h4>NAD+ Precursors (NMN/NR)</h4>
      <p>NAD+ declines 50% by age 50, impairing sirtuin activity and DNA repair. Supplementing with NMN or NR restores NAD+ levels, improving mitochondrial function, DNA repair, and metabolic health in animal models. Human trials are promising.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üßπ</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Senolytics</h4>
      <p>Drugs that selectively eliminate senescent cells. Dasatinib + Quercetin (the first senolytic combination) reduced senescent cell burden in humans. Unity Biotechnology and others are developing targeted senolytic therapies for specific age-related diseases.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üß¨</span>
      <span class="card-status status-research">Active Research</span>
      <h4>GDF11 / Young Blood Factors</h4>
      <p>Parabiosis studies showed old mice rejuvenated by young blood. GDF11 and other circulating factors appear to mediate these effects. Alkahest and other companies are developing plasma-derived rejuvenation therapies.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üåø</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Resveratrol & Senolytics</h4>
      <p>Sirtuin activators like resveratrol and newer synthetic STAC compounds target the NAD+/sirtuin longevity pathway. While resveratrol's bioavailability is limited, next-generation sirtuin activators show greater promise.</p>
    </div>
  </div>

  <!-- Genetic & Cellular -->
  <div class="tab-content" id="tab-genetic">
    <div class="intervention-card fade-in">
      <span class="card-icon">‚úÇÔ∏è</span>
      <span class="card-status status-research">Active Research</span>
      <h4>CRISPR Gene Editing</h4>
      <p>CRISPR-Cas9 can correct age-accelerating mutations, insert protective variants (like APOE2 vs APOE4), and potentially modify the genome to express longevity genes. In vivo CRISPR therapy for age-related diseases is in clinical trials.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üîÑ</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Epigenetic Reprogramming</h4>
      <p>Partial expression of Yamanaka factors (Oct4, Sox2, Klf4, c-Myc) reverses epigenetic age in cells and tissues. Altos Labs, retro Biosciences, and others are developing controlled reprogramming therapies. The eye and muscle have been rejuvenated in mice.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üß´</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Stem Cell Therapy</h4>
      <p>Replacing exhausted adult stem cells with young, functional stem cells could restore regenerative capacity to aging tissues. iPSC-derived stem cells allow personalized, immune-compatible cell therapies for organ-specific rejuvenation.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üî≠</span>
      <span class="card-status status-theoretical">Theoretical</span>
      <h4>Telomerase Activation</h4>
      <p>Activating telomerase (via gene therapy or small molecules like TA-65) could reset cellular age by rebuilding telomeres. The challenge is balancing rejuvenation with cancer risk. Controlled, tissue-specific telomerase activation remains a major research goal.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">ü¶†</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Mitochondrial Replacement</h4>
      <p>Replacing dysfunctional mitochondria or correcting mitochondrial DNA mutations through mitochondria-targeted gene therapy or mitochondrial transplantation could reverse a key driver of aging.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üíâ</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Gene Therapy Longevity Cocktails</h4>
      <p>Companies like Rejuvenate Bio are developing multigene therapies combining growth differentiation factors to address multiple aging hallmarks simultaneously. Initial results in mice show heart function, obesity, and kidney disease improvements.</p>
    </div>
  </div>

  <!-- Emerging Tech -->
  <div class="tab-content" id="tab-emerging">
    <div class="intervention-card fade-in">
      <span class="card-icon">ü§ñ</span>
      <span class="card-status status-emerging">Emerging</span>
      <h4>AI Drug Discovery</h4>
      <p>Machine learning models are accelerating identification of novel senolytics, mTOR inhibitors, and epigenetic reprogramming compounds by orders of magnitude. Insilico Medicine and others have AI-designed drugs now in clinical trials.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üß™</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Organ-on-a-Chip</h4>
      <p>Microfluidic devices replicating organ function enable rapid, personalized testing of anti-aging interventions. Combined with organoids and patient-derived cells, they bridge the gap between mouse studies and human trials.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üì°</span>
      <span class="card-status status-emerging">Emerging</span>
      <h4>Continuous Biomarker Monitoring</h4>
      <p>Wearables and implantables tracking real-time epigenetic age, circulating biomarkers, and metabolic state will enable precision longevity interventions tailored to individual biology.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">ü¶æ</span>
      <span class="card-status status-emerging">Emerging</span>
      <h4>Organ Bioprinting</h4>
      <p>3D bioprinting with patient-derived cells could replace aging or failed organs. Vascularization remains the key technical challenge. Advances in scaffold materials and bioinks are rapidly progressing.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üß¨</span>
      <span class="card-status status-emerging">Emerging</span>
      <h4>mRNA Therapeutics</h4>
      <p>Transient mRNA delivery of rejuvenating factors (including Yamanaka factors) offers controlled epigenetic reprogramming without the cancer risks of permanent gene expression. Moderna and others are exploring longevity mRNA applications.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üîã</span>
      <span class="card-status status-research">Active Research</span>
      <h4>Exosome Therapy</h4>
      <p>Young-blood exosomes carry rejuvenating signals without the risks of whole plasma. MSC-derived exosomes reduce inflammation and promote tissue repair. A potentially safer alternative to plasma transfusion.</p>
    </div>
  </div>

  <!-- Radical Approaches -->
  <div class="tab-content" id="tab-radical">
    <div class="intervention-card fade-in">
      <span class="card-icon">üíª</span>
      <span class="card-status status-theoretical">Theoretical</span>
      <h4>Mind Uploading</h4>
      <p>Whole brain emulation ‚Äî scanning the connectome in sufficient detail to simulate consciousness in silico ‚Äî would achieve digital immortality. Requires scanning resolution of nanometers across 86 billion neurons and quadrillions of synapses. Estimated feasibility: 2075-2150.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">‚ùÑÔ∏è</span>
      <span class="card-status status-emerging">Available Now</span>
      <h4>Cryonics</h4>
      <p>Vitrification of the body or brain at death for future revival. Alcor and CI currently preserve hundreds of patients. Modern vitrification protocols minimize ice crystal damage. Revival requires future technologies including nanomedical repair and new models of cellular restoration.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üî¨</span>
      <span class="card-status status-theoretical">Theoretical</span>
      <h4>Medical Nanotechnology</h4>
      <p>Robert Freitas's "nanomedicine" vision: medical nanorobots (respirocytes, microbivores, cell repair machines) operating inside the bloodstream to continuously repair molecular damage, clear cellular waste, and maintain the body indefinitely.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üß†</span>
      <span class="card-status status-theoretical">Theoretical</span>
      <h4>Neural Lace / BCI</h4>
      <p>Neuralink-style brain-computer interfaces could eventually create brain-computer symbiosis, backing up memories and personality, allowing gradual transition to substrate-independent existence as biological components are supplemented or replaced.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">üåå</span>
      <span class="card-status status-theoretical">Theoretical</span>
      <h4>Whole Body Replacement</h4>
      <p>Progressive organ replacement with bioengineered or synthetic alternatives ‚Äî from heart to liver to neurons ‚Äî leading to a Ship of Theseus scenario where the original biological components are entirely replaced with superior, non-aging versions.</p>
    </div>
    <div class="intervention-card fade-in">
      <span class="card-icon">‚öõÔ∏è</span>
      <span class="card-status status-theoretical">Theoretical</span>
      <h4>Longevity Escape Velocity</h4>
      <p>Aubrey de Grey's concept: if science extends average life expectancy by more than 1 year per year, humans alive today could live indefinitely. Current progress suggests LEV may be achievable by 2030-2050 for people in their 50s or younger.</p>
    </div>
  </div>
</section>

<!-- Roadmap -->
<section class="roadmap-section" id="roadmap">
  <div class="section-label fade-in">04 ‚Äî The Future</div>
  <h2 class="fade-in">Scientific <em>Roadmap</em><br>to Immortality</h2>

  <div class="timeline">
    <div class="timeline-item right fade-in">
      <div class="timeline-content" style="grid-column:1;text-align:right;padding:0 32px;">
        <div class="timeline-year">2024‚Äì2028</div>
        <h4>First Generation Longevity Drugs</h4>
        <p>FDA approval of senolytics and rapamycin analogs as anti-aging interventions. TAME trial concludes. First epigenetic reprogramming clinical trials begin. AI identifies 100+ novel longevity targets.</p>
      </div>
      <div class="timeline-dot"><div class="dot"></div></div>
      <div style="grid-column:3;"></div>
    </div>

    <div class="timeline-item fade-in" style="display:grid;grid-template-columns:1fr 60px 1fr;">
      <div></div>
      <div class="timeline-dot"><div class="dot"></div></div>
      <div class="timeline-content" style="padding:0 32px;">
        <div class="timeline-year">2028‚Äì2035</div>
        <h4>Epigenetic Reprogramming Therapies</h4>
        <p>Safe partial reprogramming protocols rejuvenate specific organs in humans. Combination longevity therapies targeting multiple hallmarks simultaneously enter clinical trials. Biological age reversal of 5-10 years demonstrated.</p>
      </div>
    </div>

    <div class="timeline-item fade-in" style="display:grid;grid-template-columns:1fr 60px 1fr;">
      <div class="timeline-content" style="grid-column:1;text-align:right;padding:0 32px;">
        <div class="timeline-year">2035‚Äì2045</div>
        <h4>Comprehensive Rejuvenation</h4>
        <p>Combination therapies achieve 20+ year biological age reversal. Gene therapies correct susceptibility variants. Stem cell and organoid therapies replace failing organs. Longevity becomes standard medical care.</p>
      </div>
      <div class="timeline-dot"><div class="dot"></div></div>
      <div style="grid-column:3;"></div>
    </div>

    <div class="timeline-item fade-in" style="display:grid;grid-template-columns:1fr 60px 1fr;">
      <div></div>
      <div class="timeline-dot"><div class="dot"></div></div>
      <div class="timeline-content" style="padding:0 32px;">
        <div class="timeline-year">2045‚Äì2060</div>
        <h4>Longevity Escape Velocity</h4>
        <p>Annual gains in healthy lifespan exceed 1 year. For those alive and healthy, biological aging becomes optional. First humans maintain biological age below 30 indefinitely. Cryonics revival becomes plausible.</p>
      </div>
    </div>

    <div class="timeline-item fade-in" style="display:grid;grid-template-columns:1fr 60px 1fr;">
      <div class="timeline-content" style="grid-column:1;text-align:right;padding:0 32px;">
        <div class="timeline-year">2060‚Äì2100</div>
        <h4>Post-Aging Civilization</h4>
        <p>Biological aging effectively cured for most of humanity. Neural interfaces allow memory preservation and augmentation. The boundary between biological and artificial existence becomes navigable. Death from aging becomes rare.</p>
      </div>
      <div class="timeline-dot"><div class="dot"></div></div>
      <div style="grid-column:3;"></div>
    </div>
  </div>
</section>

<!-- Hypotheses -->
<section class="hypotheses-section" id="hypotheses">
  <div class="section-label fade-in">05 ‚Äî Open Questions</div>
  <h2 class="fade-in">Key <em>Hypotheses</em><br>& Debates</h2>

  <div class="hypothesis-accordion">
    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>Is aging programmed or stochastic?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          One of biology's deepest debates: does aging result from a genetic program (like development), or is it simply the accumulation of random damage over time? The programmed view suggests we could "turn off" aging by disabling specific genetic switches. The damage/stochastic view suggests we need to continuously repair damage. Modern evidence supports both: the epigenetic clock suggests programmatic elements, while mitochondrial and DNA damage clearly accumulate stochastically. The answer likely lies in a hybrid model where a damage-sensing program drives aging acceleration.
        </div>
      </div>
    </div>

    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>Can epigenetic reprogramming be done safely in living humans?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          Full reprogramming (all four Yamanaka factors) causes teratoma formation. The challenge is achieving partial reprogramming ‚Äî restoring epigenetic youth without erasing cellular identity. OSK (Oct4, Sox2, Klf4 without c-Myc) has shown promise in retinal neurons and other tissues in mice. The key question is whether tissue-specific, dose-controlled reprogramming can be achieved in humans without oncogenic risk. Early safety trials are now beginning, and the field is watching closely.
        </div>
      </div>
    </div>

    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>Is there a maximum human lifespan, or is it unlimited?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          Jeanne Calment lived to 122. Some researchers argue a hard biological limit exists around 125-150 years. Others, like Aubrey de Grey, argue there is no theoretical maximum ‚Äî aging is simply damage accumulation, and sufficient repair could maintain the body indefinitely. The existence of negligibly senescent organisms (lobsters, hydra, naked mole rats) demonstrates that biological aging is not universal, strongly suggesting that with sufficient intervention, maximum human lifespan could be dramatically extended or eliminated.
        </div>
      </div>
    </div>

    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>Will AI dramatically accelerate longevity research?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          AlphaFold's protein structure predictions transformed structural biology overnight. Similar AI breakthroughs in aging research could compress decades of work into years. AI systems are already identifying novel drug candidates, predicting treatment outcomes from biomarker profiles, and designing clinical trials. The convergence of AI with aging biology may be the key catalyst that brings longevity escape velocity within reach in our lifetimes, with systems like those developed by Insilico Medicine, BioAge Labs, and others leading the charge.
        </div>
      </div>
    </div>

    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>What are the ethical implications of radical life extension?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          If radical life extension becomes possible, profound ethical questions arise: Will it only be available to the wealthy, creating a biologically immortal elite? How would overpopulation be managed? Would century-old power structures prevent generational change? Would people tire of living? Proponents argue longevity would reduce suffering, allow accumulated wisdom, and give individuals more time to contribute to civilization. Equitable access, societal adaptation, and psychological preparation are as important as the science itself.
        </div>
      </div>
    </div>

    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>Which single intervention is most likely to achieve the greatest impact?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          Among current candidates, epigenetic reprogramming is considered most transformative by many longevity researchers, as it addresses the upstream information loss rather than individual downstream damage types. Senolytics offer perhaps the clearest near-term clinical benefit with existing drugs. mTOR inhibition (rapamycin) has the most consistent animal data. A combination therapy addressing multiple hallmarks simultaneously is likely more effective than any single intervention. The "longevity stack" approach ‚Äî combining caloric restriction, exercise, senolytics, rapamycin, NAD+ precursors, and epigenetic interventions ‚Äî is the current leading hypothesis for near-term maximum benefit.
        </div>
      </div>
    </div>
  </div>
</section>

<!-- Pioneering Companies -->
<section class="companies-section">
  <div class="section-label fade-in" style="justify-content:center;">06 ‚Äî The Ecosystem</div>
  <h2 class="fade-in">Pioneering <em>Organizations</em></h2>
  <p class="fade-in" style="max-width:600px;margin:0 auto 0;">The longevity industry has attracted billions in investment. These are the organizations pushing the frontier of aging science.</p>

  <div class="companies-grid fade-in">
    <div class="company-cell">
      <span class="company-name">ALTOS LABS</span>
      <span class="company-focus">Epigenetic Reprogramming</span>
      <span class="company-desc">$3B backed. Developing cellular rejuvenation programming to restore youthful biology.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">CALICO</span>
      <span class="company-focus">Longevity Research</span>
      <span class="company-desc">Google/Alphabet's longevity moonshot. Basic research into the biology of aging.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">UNITY BIOTECH</span>
      <span class="company-focus">Senolytics</span>
      <span class="company-desc">Clinical-stage company developing senolytic therapies for age-related diseases.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">RETRO BIOSC.</span>
      <span class="company-focus">Reprogramming</span>
      <span class="company-desc">Sam Altman-backed. Partial cellular reprogramming and plasma dilution therapies.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">INSILICO MED.</span>
      <span class="company-focus">AI Drug Discovery</span>
      <span class="company-desc">AI-powered aging target identification and drug candidate generation.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">BIOAGE LABS</span>
      <span class="company-focus">Biomarkers + Drugs</span>
      <span class="company-desc">Machine learning on blood biomarkers to develop precision longevity therapies.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">SENS RESEARCH</span>
      <span class="company-focus">Damage Repair</span>
      <span class="company-desc">Aubrey de Grey's foundation targeting all 7 categories of age-related molecular damage.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">HALLMARK BIO</span>
      <span class="company-focus">Combination Therapy</span>
      <span class="company-desc">Developing multi-hallmark combination therapies for comprehensive aging intervention.</span>
    </div>
  </div>
</section>

<!-- Manifesto -->
<section class="manifesto">
  <div class="manifesto-inner fade-in">
    <div class="section-label" style="justify-content:center;margin-bottom:40px;">Our Belief</div>
    <div class="manifesto-quote">
      "Death is not <em>inevitable.</em> Aging is not natural law. It is a disease ‚Äî and every disease has a cure. The greatest project in human history has already begun."
    </div>
    <p style="color:var(--muted);font-size:16px;max-width:500px;margin:0 auto 40px;text-align:center;">The science is ready. The technology is converging. The only question is: how fast can we move?</p>
    <a href="#aging" class="btn-primary"><span>Begin from the Start</span></a>
  </div>
</section>

<!-- Footer -->
<footer>
  <div class="footer-logo">BIO<span>FIN</span>ITY</div>
  <div class="footer-text">
    An open-source longevity research hub<br>
    Built for the pursuit of human immortality
  </div>
  <div class="footer-links">
    <a href="#aging">Science</a>
    <a href="#interventions">Interventions</a>
    <a href="#roadmap">Roadmap</a>
    <a href="https://github.com" target="_blank">GitHub</a>
  </div>
</footer>

<script>
  // Custom cursor
  const cursor = document.getElementById('cursor');
  const ring = document.getElementById('cursorRing');
  let mouseX = 0, mouseY = 0, ringX = 0, ringY = 0;

  document.addEventListener('mousemove', (e) => {
    mouseX = e.clientX;
    mouseY = e.clientY;
    cursor.style.left = mouseX - 4 + 'px';
    cursor.style.top = mouseY - 4 + 'px';
  });

  function animateRing() {
    ringX += (mouseX - ringX) * 0.12;
    ringY += (mouseY - ringY) * 0.12;
    ring.style.left = ringX + 'px';
    ring.style.top = ringY + 'px';
    requestAnimationFrame(animateRing);
  }
  animateRing();

  document.querySelectorAll('a, button, .accordion-header, .hallmark-card, .intervention-card, .company-cell').forEach(el => {
    el.addEventListener('mouseenter', () => {
      cursor.style.transform = 'scale(3)';
      ring.style.transform = 'translate(-50%, -50%) scale(1.5)';
      ring.style.borderColor = 'rgba(0,229,255,0.7)';
    });
    el.addEventListener('mouseleave', () => {
      cursor.style.transform = 'scale(1)';
      ring.style.transform = 'translate(-50%, -50%) scale(1)';
      ring.style.borderColor = 'rgba(0,229,255,0.4)';
    });
  });

  // Tabs
  function switchTab(name) {
    document.querySelectorAll('.tab-content').forEach(t => t.classList.remove('active'));
    document.querySelectorAll('.tab-btn').forEach(b => b.classList.remove('active'));
    document.getElementById('tab-' + name).classList.add('active');
    event.target.classList.add('active');
  }

  // Accordion
  function toggleAccordion(header) {
    const item = header.parentElement;
    const isOpen = item.classList.contains('open');
    document.querySelectorAll('.accordion-item').forEach(i => i.classList.remove('open'));
    if (!isOpen) item.classList.add('open');
  }

  // Scroll animations
  const observer = new IntersectionObserver((entries) => {
    entries.forEach(entry => {
      if (entry.isIntersecting) {
        entry.target.classList.add('visible');
      }
    });
  }, { threshold: 0.1, rootMargin: '0px 0px -50px 0px' });

  document.querySelectorAll('.fade-in').forEach(el => observer.observe(el));

  // Counter animation for stats
  function animateCounter(el, target, suffix = '') {
    let current = 0;
    const duration = 2000;
    const step = target / (duration / 16);
    const timer = setInterval(() => {
      current += step;
      if (current >= target) {
        current = target;
        clearInterval(timer);
      }
      if (suffix === 'T') el.textContent = Math.round(current) + 'T';
      else if (suffix === 'B+') el.textContent = '$' + current.toFixed(0) + 'B+';
      else el.textContent = Math.round(current) + suffix;
    }, 16);
  }

  const statsObserver = new IntersectionObserver((entries) => {
    entries.forEach(entry => {
      if (entry.isIntersecting) {
        const nums = entry.target.querySelectorAll('.stat-num');
        nums[0] && animateCounter(nums[0], 150, 'T');
        nums[1] && animateCounter(nums[1], 12, '');
        nums[2] && animateCounter(nums[2], 5, 'B+');
        nums[3] && animateCounter(nums[3], 2050, '');
        statsObserver.disconnect();
      }
    });
  }, { threshold: 0.5 });

  const statsBar = document.querySelector('.stats-bar');
  if (statsBar) statsObserver.observe(statsBar);

  // Nav scroll effect
  window.addEventListener('scroll', () => {
    const nav = document.querySelector('nav');
    if (window.scrollY > 100) {
      nav.style.background = 'rgba(3,5,8,0.97)';
      nav.style.borderBottom = '1px solid rgba(0,229,255,0.08)';
    } else {
      nav.style.background = 'linear-gradient(to bottom, rgba(3,5,8,0.95), transparent)';
      nav.style.borderBottom = 'none';
    }
  });
</script>
</body>
</html>
